Detalhe da pesquisa
1.
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
Clin Infect Dis
; 76(3): e607-e612, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004410
2.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med
; 383(19): 1827-1837, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459919
3.
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany.
HIV Med
; 24(4): 389-397, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059149
4.
Clinical and virological features of first human monkeypox cases in Germany.
Infection
; 51(1): 265-270, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816222
5.
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
Infection
; 51(4): 1033-1049, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763285
6.
Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany.
BMC Infect Dis
; 23(1): 89, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765274
7.
[Measures and Recommendations for Ensuring Adequate Inpatient Care Capacities for Pandemic Management within a Region: Results of a Hybrid Delphi Method]. / Maßnahmen und Empfehlungen für die Sicherstellung adäquater stationärer Versorgungskapazitäten für das Pandemiemanagement innerhalb einer Region Ergebnisse eines hybriden Delphi-Verfahrens.
Gesundheitswesen
; 85(12): 1173-1182, 2023 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-37604173
8.
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.
Clin Infect Dis
; 75(5): 786-794, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996113
9.
Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany.
Emerg Infect Dis
; 28(3): 572-581, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195515
10.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Infection
; 50(2): 423-436, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625912
11.
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning.
Infection
; 50(2): 359-370, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34279815
12.
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Infection
; 50(1): 93-106, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228347
13.
Health-related quality-of-life in people living with HIV after switching to dual therapy with ritonavir-boosted darunavir + dolutegravir: a DUALIS sub-study.
AIDS Care
; 34(6): 698-707, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896276
14.
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
Cochrane Database Syst Rev
; 6: CD014945, 2022 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713300
15.
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
Euro Surveill
; 27(14)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393933
16.
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Euro Surveill
; 27(48)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695464
17.
[Antiviral drugs : Potent agents, promising therapies for COVID19 and therapeutic limitations]. / Antivirale Medikamente : Potente Wirkstoffe, Hoffnungsträger bei COVID19 und therapeutische Grenzen.
Internist (Berl)
; 63(1): 118-128, 2022 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-34988607
18.
Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.
HIV Med
; 22(5): 372-378, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368966
19.
Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients.
J Med Virol
; 93(12): 6703-6713, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331717
20.
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic.
Respir Res
; 22(1): 119, 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892720